Atherosclerosis Flashcards

(46 cards)

1
Q

What is atherosclerosis ?

A
  • Lipoprotein-driven disease that leads to
    plaque formation at specific sites of the
    arterial tree through intimal
    inflammation, necrosis, fibrosis, and
    calcification
  • Leads to narrowing of the arteries; more
    susceptible to formation of thrombi or
    plaque rupture
  • Obstruction of blood flow to the heart,
    brain or lower extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Steps of plaque formation

A
  1. Endothelial Damage
    Hypertension, inflammation, smoking etc
  2. Circulating LDL is taken up
    LDL becomes oxidised and stimulates and
    inflammatory response
  3. Adhesion molecules are upregulated
    on endothelial cells and monocytes
    are recruited
  4. Monocytes differentiate into
    macrophages which phagocytose oxidisedLDL and turn into foam cells
  5. T-cells release cytokines, which further activate macrophages
  6. Smooth muscles cells proliferate and migrate into the intimal layer and form a fibrous cap
  7. Smooth muscle cells synthesise extracellular
    matrix proteins and become less contractile
  8. Angiogenesis; new vessel formation within
    the plaque.
  9. Dead cells and lipids released from the dead cells
    accumulate within the plaque creating a necrotic/ lipid core
  10. Fibrous cap can become unstable and rupture causing thrombus formation
  11. Vascular calcification; smooth muscle cells differentiate into osteoblast-like cells. Angiogenesis; new vessel formation within the
    plaque. The new vessels may lack stability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Endothelial cells

A

 Master controllers of the artery
 Control size of the artery - dilation and constriction
 Control transport of molecules across artery
 Control transport of immune cells across artery
 Exist on a spectrum between activated or quiescent states
Turbulent flow patterns cause cells to become activated
Activated endothelial cells are more leaky
They let more fat particles (LDL) through the artery wall
Activated cells attract immune cells to the area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Endothelial dysfunction

A

 Disturbed flow primes the endothelium for dysfunction/inflammation
 Lifestyle factors can cause endothelial dysfunction – e.g. smoking,
diabetes, hypertension
 Poor diet provides limited essential nutrients and antioxidants also
limiting endothelial health and protection from other risk factors
 The combination of disturbed flow and other risk factors promotes
plaque formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Angiogenesis and instability

A
  • New or neo vessels originating from the vasa vasorum - new point for inflammatory infiltration
  • Neo vessels lack stability due to lack of recruitment of mural cells; can be ‘leaky’
  • May help expand the necrotic core
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Smooth Muscle cell

A

 Produce the collagen that gives strength to the artery
 Control size of the artery - dilation and constriction
 Proliferation and migration are suppressed by a functional endothelium –
endothelial dysfunction takes off the handbrake
 They also respond to the developing damage caused by the plaque that triggers
further proliferation and also de-differentiation
 Responsible for forming and maintaining the fibrous cap – cell death
(apoptosis) leads to weakening of the fibrous cap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does vascular calcification occur

A

It is a regulated process involving differentiation of VSMCs.

Environment: Oxidative stress, glucose, inflammation, hypoxia, DNA damage -> affecting contractile smooth muscle cells -> causing osteogenic differentiation -> causing secretory smooth muscle cells which deposit calcium phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lesion types of atherosclerosis; proposed sequence of development

A

Xanthoma; Accumulation of
foam cells without a necrotic
core, fibrous cap or thrombosis

Fibrous caps; high content of
collagen I and proteoglycans
and elastin produced by
differentiated SMCs
Osteoblastic and contractile
phenotype reduced

Necrotic core; Acellular mix of
lipid and debris caused by
apoptosis and necrosis of
macs/foam cells, SMCs

Adaptable intimal thickning -> Xanthoma -> Pathological intimal thickening -> Necrotic core -> Fibrocalcific plaque

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Atherosclerosis

A

Endothelial activation -> inflammatory cell infiltration -> atherosclerosis -> vascular calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RFs for endothelial activation

A

Risk factors,
inflammation, ox
stress, diabetes,
LDL, cholesterol,
turbulent flow
etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where do plaques normally occur?

A

Sites of low oscillatory/disturbed shear stress- at branch points
They primarily occur at regions of disturbed blood flow patterns
 This is typically seen at bifurcations (branch points) in arteries
 Curved sections of artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Endothelial cells respond to shear stress

A

Disturbed flow
- Response to inflammatory stimuli
* Reactive oxygen species production
* Permeability
* Apoptosis and proliferation
* Bioavailability of nitric oxide (NO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RFs for plaque formation

A
  • HTN
  • High blood lipids
  • Age
  • Atherosclerosis
  • Diabetes, lupus etc
  • Genetics e.g. HF
  • Lifestyle - smoking, inactivity, XS alcohol, obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk Factors… Smoking

A

 Cigarette smoke contains between 5-8000 different chemicals
 Also contains very large amounts of free radicals
 Damage the lungs and increases systemic levels of inflammatory
cytokines
 Soluble chemicals circulate in blood and induce endothelial dysfunction
 ‘Toxic’ damage response to chemical components
 Oxidative damage response to free radicals
 Chronic stress response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Risk Factors… Diet

A

 Excessive intake of saturated and hydrogenated fats increases circulating
cholesterol and triglyceride levels
 High salt diet increases risk of hypertension
 High sugar diet increases risk of diabetes
 Low fruit and veg diet limits the intake of antioxidants
 Low fruit and veg diet limits the intake of vitamins, increasing susceptibility to
disease and associated increase in inflammatory cytokine levels
 Low fibre diet limits the body’s ability to excrete excess cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk Factors… Inactivity

A

 Low activity levels promotes endothelial dysfunction
 Activity increases blood flow over endothelial cells (shear stress) and the protective mechanisms triggered by laminar shear stress
 Regular activity increases the amount of glucose stored as glycogen in muscles, reducing risk of diabetes
 Reduces blood pressure and increases HDL production
 Aerobic activity: Get at least 150 minutes of moderate aerobic activity or 75
minutes of vigorous aerobic activity a week, or a combination of moderate and vigorous activity. (don’t drive to work… 15 minutes brisk walk twice a day will reduce your risk of a heart attack)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk Factors… Diabetes

A

 Increases circulating glucose levels, which in turn increases the production
of oxygen free radicals
 Increases production of advanced glycation end products (AGEs) which damage cells and artery wall
 Insulin reduction/ absence (type 1 or insensitivity (type 2)
 Compounded with other risk factors
 Diabetics are 2-4 times more likely to have a heart attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Risk Factors… Hypertension

A

 Increases/linked to endothelial dysfunction
 Increases thickness and stiffness of artery wall
 Increased/modification of artery wall potentially increases trapping of LDL in
artery wall and atherosclerosis
 Increases production of reactive oxygen species (free radicals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

‘Heart attacks’ - v cardiac arrest

A

Heart attack: One of the coronary arteries becomes blocked leading to a decrease in blood supply to the heart muscle. If left untreated, the cells will begin to die because there isn’t enough oxygen.
Cardiac arrest: when the heart stops pumping blood around the body and patient stops breathing normally

20
Q

Vulnerable vs stable plaque

A

Vulnerable plaque - thin fibrous cap, large lipid pool, many inflammatory cells, few smooth muscle cells -> CV event

Measures that may stabilises an atheroma = Decrease LDLs, increase HDLs, decrease angiotensin II, decrease insulin resistance, decrease oxidative stress, decrease blood pressure

-> causing it to become a stable plaque - thick fibrous cap, smaller lipid pool, few inflammatory cells, dense extracellular matrix

21
Q

Atherosclerotic Plaque Rupture

A

 Accounts for ~65% type 1 MI
 Rupture of fibrous cap allowing blood to communicate with the lipid rich necrotic core, precipitating a thrombus.
 Proinflammatory, macrophage driven
 Plaques have thin fibrous caps and large lipid cores
 Frequently expansively remodelled
 Smooth muscle cell apoptosis and Matrix degradation
 Biomechanical failure of fibrous cap

Rupture of a thin-cap fibroatheroma with nonfatal thrombus and subsequent healing with fibrous tissue formation and constrictive remodelling

22
Q

Endothelial Erosion

A

 Accounts for ~31% Type 1 MI
 Endothelial erosion, loss of endothelial cells overlying a plaque that precipitates a thrombus
 Predominantly an endothelial pathology
 Little involvement of inflammatory cells (e.g. macrophage)
 Endothelial loss overlying a thick fibrous cap
 Smooth muscle rich sub endothelial matrix
 Cigarette smoking an identified risk factor

23
Q

Plaque composition

A

Ruptured plaque - occlusive thrombus, fractured thin fibrous cap, high macrophage infiltration, large lipid core, expansively remodelled artery

Eroded plaque - Partially occlusive thrombus, proteoglycan, hyaluronan and smooth muscle cell-rich sub endothelial matrix, thick fibrous cap, small deep-seated lipid core
Smoking and female gender are strong risk factors for erosion
Other contributors to erosion;
endothelial dysfunction, leukocyte activation, modification of sub-endothelial matrix by endothelial or SMCs, leading to loss of adhesion to the ECM or apoptosis

24
Q

Blood flow and shear stress

A
  • Endothelial activation can occur in regions of elevated shear stress
  • Elevated flow may play a role in both plaque rupture and plaque erosion
  • Endothelial cells change their behaviour depending on the flow pattern they experience
25
What are the pathological consequences of atherosclerosis?
* Carotid artery disease - Ischaemic stroke * Peripheral arterial disease * Coronary artery disease Angina and Unstable Angina Acute Myocardial Infarction (AMI)
26
Ischaemic heart disease (Angina)
* Obstruction and/or spasm of the coronary arteries decreases the oxygen supply to the myocardium. * Symptoms are chest pain, the chest feels tight, may spread to arms, neck or jaw * Symptoms are precipitated by exercise, stress and cold * Symptoms may stop after a few minutes of rest * Stable angina usually have a trigger as above * Unstable angina is more unpredictable and can continue despite resting and may result in an eventual MI, so treatment with nitrate, Ca2+ channel or β-blockers is advised in the 1st instance * Lifestyle changes – see risk factors
27
Acute myocardial infarction
* Occurs when one of the coronary arteries become occluded by a plaque or an embolus, leading to heart muscle ischaemia * Severity depends on 3 factors -The level of the occlusion in the coronary artery -Length of time of the occlusion -Presence or absence of collateral circulation * Death of myocardial cells; as the duration of the occlusion increases, the area of myocardial cell death enlarges
28
Type 1 MI
Spontaneous myocardial infarction related to ischaemia due to a primary coronary event such as plaque erosion and/or rupture
29
Type 2 MI
Myocardial infarction secondary to ischaemia due to either increased oxygen demand or decreased supply eg. coronary artery spasm, coronary embolism, anaemia, arrhythmias, hypertension or hypotension, sudden coronary artery dissection
30
Type 3 MI
Sudden unexpected cardiac death, including cardiac arrest, often with symptoms suggestive of m ischaemia, accompanied by presumably new ST elevation, or new LBBB, or evidence of fresh thrombus in a coronary artery by angiography and/or autopsy, but death occurring before blood samples could be obtained, or at a time before the appearance of cardiac biomarkers in blood
31
Type 4 MI
4a - MI associated with PCI 4b - MI associated with stent thrombosis as documented by angiography or at autopsy
32
Type 5 MI
MI associated with CABG
33
ESC definition of MI
Presence of acute myocardial injury detected by abnormal cardiac biomarkers in the setting of evidence of acute myocardial ischaemia Criteria for myocardial injury - detection of elevated cardiac troponin values above 99th percentile upper reference limit is defined as myocardial injury. The injury is considered acute if there is a rise/fall of cTn values.
34
Universal definition of myocardial infarction * Serum troponin is also be elevated (indicates cardiac muscle death) Serum and plasma markers of cardiac damage
3 sub-units that regulate the calciummediated contractile process of striated muscle * Troponin C- binds Ca2+ * Troponin I (TnI)– binds to actin and inhibits actin-myosin interactions * Troponin T (TnT) – binds to tropomyosin; attaching the troponin complex to the thin filament. * Small amount TnT (6-8%) and TnI (2-3%) is within the cytosol pool * After injury initial release is from the pool, followed by the myofilament bound protein * These can be detected by specific antibodies
35
Commercial assays
* Different commercial assays available; different reference levels as use antibodies to different epitopes -Lab-specific cut off values * High sensitivity cardiac troponin – more precise measurement of very low levels * Hs cTn developed for rapidly changing levels over periods of 1-3 hours * Improved diagnosis of AMI from underlying structural heart disease (left ventricular hypertrophy) * Other biomarkers; * CRP – inflammatory response * Natriuretic peptides reflect haemodynamic impact of MI associated with prognosis New biomarkers should focus on unmet clinical need eg Type I vs type 2 MI, plaque rupture vs erosion
36
Clinical measures and diagnostic approaches
* Electrocardiography * Echocardiography - helpful to identify which areas of the heart are damaged * Coronary angiography * Imaging is key to determine extent of the infarct
37
Model for interpreting M injury and MI
Elevated Cardiac Troponin >99th percentile URL -> Troponin rise and/ or fall -> Trops level stable -> Troponin rise and/ or fall -> With acute ischaemia -> without acute ischaemia -> With acute ischaemia - > acute MI due to: -> atherosclerosis + thrombosis (Type 1 MI: triggers: plaque rupture, plaque erosion) -> oxygen supply and demand imbalance (Type 2: examples: severe hypertension, sustained tachyarrhythmia) -> without acute ischaemia -> acute myocardial injury -> examples: acute HF, myocarditis Trops level stable -> chronic myocardial injury -> examples: structural heart disease, chronic kidney disease
38
Treatment of coronary artery disease: primary percutaneous coronary intervention (PCI)
Firstly, coronary angiography using contrast agent to determine location of blockage, followed by coronary angioplasty * STEMI - angioplasty can be used to ‘unblock’ coronary arteries * NSTEMI usually treated by blood thinning drugs eg aspirin, clopidogrel; however further treatment is required in some cases
39
Treatment of coronary artery disease: Angioplasty
 Local anaesthesia Insert a catheter into artery using guide wires via groin or wrist Rotablation may be used if the blockage is particularly hard which uses a special catheter with a tiny drill at its tip, powered by compressed air  This will chip away at the plaque to gradually widen the narrowing, then angioplasty can proceed as normal 1) the balloon and stent are positioned in the narrowed part of artery 2) the balloon is inflated and the stent expands, pushing the plaque back against the artery wall 3) The balloon is then deflated and removed, leaving the stent propping open the the artery 4) The widened artery improves blood flow to the heart muscle
40
Coronary artery bypass graft surgery (CABG)
* Coronary artery bypass graft (CABG) is performed in patients with advanced atherosclerosis and/or multi-vessel disease * The procedure involves grafting a vessel from another part of the body, often the saphenous vein or IMA, to bypass the CA blockage * The increased blood flow to the heart muscle reduces the chance of myocardial infarction * Major operation under GA lasts 2.5 hours + recovery * Attend rehabilitation classes - Grafting can be performed as a single, double, triple and even quadruple procedure
41
On vs off-pump CABG
* CABG involves using a heart-lung bypass machine to pump blood and oxygen around the body whilst the heart is temporarily stopped * More surgeons are performing off pump CABG where the heart is still beating whilst the new grafts are attached * OPCABG often takes less time, can reduce bleeding, and reduce hospital stays * It is also thought to reduce oxidative stress and platelet activation as blood isn’t pumped through plastic tubes * It is technically more demanding and more difficult for multiple bypasses (see NICE guidelines)
42
Comparative anatomy - using a vein for an artery
Vein graft adapts to arterial conditions of pressure Venous = 10 mm Hg Arterial = 100 mm Hg
43
Drug Treatments for CVD
5 General classes of drugs 1. Lipid lowering medication Statins : Inhibit HMG-CoA reductase – the enzyme responsible for the production of cholesterol in the liver NICE recommend in patients with >20% 10 year CVD risk (10% soon…) Can decrease CVD risk by up to 60% - Reasonably well-tolerated and cheap Inclisiran drug siRNA to block PCSK9 protein which prevents recycling of LDL receptor, increasing uptake of LDL-cholesterol instead. 2. Cardioinhibitory - beta-blockers, Beta-Adrenergic Blocking Agents, Decreases the heart rate and cardiac output- lowers blood pressure and makes the heart beat more slowly and with less force. Calcium Channel Blockers – affects Ca movement in and out of the cell - Used to lower blood pressure, chest pain Diuretics relieve the heart's workload lowers blood pressure 3. Anti-coagulants - Decreases the clotting (coagulating) ability of the blood Drug Treatments Continued * Thrombolytics (alteplase) * Anti-platelets (aspirin, clopidogrel) * Anti-coagulents (eg warfarin, apixaban) 4. Vasodilators: Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors) + Angiotensin Receptor Blockers (ARBs) 5. Cardiostimulatory or inotropic drugs (stimulate contractility) - Digitalis. Used to relieve heart failure symptoms, especially when the patient isn’t responding to ACE inhibitors and diuretics. Also slows certain types of irregular heartbeat (arrhythmias) Control of other diseases with increased risk of CVD SLE/Lupus; anti-TNFα, hydroxychloroquine, steroids CKD; dialysis, transplant Control of diabetes; Insulin, Metformin – reduces hepatic glucose production Sulfonylureas – stimulate insulin secretion Giltazones – increase insulin sensitivity
44
Changes in lifestyle
* Stop smoking * Regular exercise/activity * Healthy diet * Manage stress * Limit alcohol intake Think about how these drugs/lifestyle changes target the risk factors and how they may impact on the underlying mechanisms driving disease
45
Optical Coherence Tomography; OCT
* Provides in vivo imaging of plaque morphology * Uses near-infrared electromagnetic radiation to generate cross sections (measures echo time delay and intensity of light reflected back) * Can be used for 3D construction * Potential identify sub-clinical lesions * Invasive * Improved understanding of mechanisms underlying the pathology in CAD
46
Future innovation
* Imaging - – how to spot a (rupture) vulnerable plaque * Blood biomarkers for vulnerable plaque * Precision medicine and development of new patient pathways to better identify patients for drug treatment/ preventative medicine